|
2004
Beal MF, Ferrante RJ. Experimental therapeutics in transgenic mouse models of Huntington's Disease. Nature Reviews Neuroscience 2004; 373-384. [PubMed]
Brown J III, Theisler C, Silberman S, Magnuson D, Gottardi-Littell N, Lee JM, Yager D, Crowley J, Sambamurti K, Rahman MM, Reiss AB, Eckman CB, Wolozin B. Differential expression of cholesterol hydroxylases in Alzheimer’s disease. The Journal of Biological Chemistry 2004; 279:34674-34681. [PDF]
Cosentino SA, Jefferson AL, Carey ME, Price CC, Davis, KL, Swenson R, Libon DJ. An analysis of different diagnostic criteria for vascular dementia. The Clinical Neuropsychologist 2004; 18:6-21. [PDF]
Cosentino SA, Jefferson AL, Kaplan E, Chute D, Libon DJ. Clock drawing errors in dementia: Neuropsychological and neuroanatomical considerations. Behavioral & Cognitive Neurology 2004; 17:74-83. [PDF]
Cupples LA, Farrer LA, Sadovnick AD, Relkin N, Whitehouse P, Green R.C. Estimating risk curves for first-degree relatives of patients with Alzheimer’s disease: The REVEAL study. Genetics in Medicine 2004; 6:192-196. [PDF]
Dedeoglu A, Choi JK, Cormier K, Kowall NW, Jenkins BG. Magnetic resonance spectroscopic analysis of Alzheimer’s disease mouse brain that express mutant human APP shows altered neurochemical profile. Brain Research 2004; 1012:60-65. [PubMed]
Ferrante RJ, Ryu H, Kubilus JK, D'Mello S, Sugars KL, Lee J, Lu P, Smith K, Browne B, Beal MF, Kristal BS, Stavrovskaya IG, Hewett S, Rubinsztein DC, Langley B, Ratan RR. Chemotherapy for the brain: The antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease. Journal of Neuroscience 2004; 24(46):10335-10342. [PubMed]
Gao W, Eisenhauer PB, Conn K, Lynch JA, Wells JM, Ullman MD, McKee A, Thatte HS, Fine RE. Insulin degrading enzyme is expressed in the human cerebrovascular endothelium and in cultured human cerebrovascular endothelial cells. Neuroscience Letters. 2004; 371: 6-11. [PubMed]
Eisenhauer PB, Jacewicz MS, Conn KJ, Koul O, Wells JM, Fine RE, Newburg DS. Escherichia coli Shiga toxin 1 and TNF-a induce cytokine release by human cerebral microvascular endothelial cells. Microbial Pathogenesis 2004; 36:189-196. [PubMed]
Roberts JS, Barber M, Brown TM, Cupples LA, Farrer LA, LaRusse SA, Post SG, Quaid KA, Ravdin LD, Relkin NR, Sadovnick D, Whitehouse PJ, Woodard JL, Green RC. Who seeks genetic susceptibility testing for Alzheimer’s disease? Findings from a multisite, randomized clinical trial. Genetics in Medicine 2004; 6:197-203. [PDF]
Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES, Steinburg MH, Nolan V, Baldwin CT, Hotchkiss RS, Buchman TG, Zehnbauer BA, Hayden MR, Farrer LA, Roy S, Nicholson DW. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphs. Nature 2004; 429:75-79. [PubMed]
|
|
